We are excited to announce the launch of Nanograb, a computational drug discovery company that uses AI to generate the best combination of binders for the highly precise targeting of drug delivery systems.

Nanograb stems from the academic collaboration between the Stevens Group and the group of Dr Stefano Angioletti-Uberti. Read more about the company and the exciting science behind it.